secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2023-05-25T23:59:59+00:00
Accession:  0001104659-23-064653
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharma shareholders approve all proposals at 2023 annual meeting
--------------------------------------------------------------------

- All eight director nominees elected; Thomas Haughey received 9.90M for, 4.11M against, highest against.
- Ratification of EisnerAmper as FY2023 auditor approved: 14.96M for, 95.96K against.
- Advisory say-on-pay approved: 13.21M for, 780.34K against, 19.91K abstain.
- 2023 amendment to 2022 Stock Incentive Plan approved: 12.83M for, 1.17M against.
- Broker non-votes of 1.05M on all proposals except auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923064653/0001104659-23-064653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923064653/tm2316594d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-064653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer